0001144204-19-019917.txt : 20190416 0001144204-19-019917.hdr.sgml : 20190416 20190416170110 ACCESSION NUMBER: 0001144204-19-019917 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190415 FILED AS OF DATE: 20190416 DATE AS OF CHANGE: 20190416 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ciraolo Michael CENTRAL INDEX KEY: 0001772484 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38045 FILM NUMBER: 19751515 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Neurotrope, Inc. CENTRAL INDEX KEY: 0001513856 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463522381 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: (973) 242-0005 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: BlueFlash Communications, Inc. DATE OF NAME CHANGE: 20110223 4 1 tv519017_4.xml OWNERSHIP DOCUMENT X0306 4 2019-04-15 0 0001513856 Neurotrope, Inc. NTRP 0001772484 Ciraolo Michael C/O NEUROTROPE, INC. 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 0 1 0 0 COO and General Counsel Stock Option (right to buy) 5.67 2019-04-15 4 A 0 100000 0 A 2029-04-15 Common Stock 100000 100000 D These securities were issued in connection with the Reporting Person's appointment as a Chief Operating Officer and General Counsel to the Issuer. 25% of the options vest on the date of grant, with the remaining 75% vesting in equal monthly installments over a two year period beginning on April 1, 2019. /s/ Michael Ciraolo 2019-04-16